Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter

Journal of Immunology

Volumn 164, Issue 2, 2000, Pages 825-832

  Chen, Rongbing ^a   Burke, Thomas F ^a   Cumberland, John E ^a   Brummet, Mary ^a   Beck, Lisa A ^a   Casolaro, Vincenzo ^a   Georas, Steve N ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CALCINEURIN; CALCIUM ION; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 4;

ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE ACTIVATION; TRANSACTIVATION;

EID: 0034650405     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.2.825     Document Type: Article

References (73)

1. Schleimer, R., L. Beck, L. Schwiebert, C. Stellato, K. Davenpeck, and B. Bochner, 1997. Inhibition of inflammatory cell recruitment by glucocorticoids: cytokines as primary targets. In Inhaled Glucocorticoids in Asthma. R. P. Schleimer, W. Busse, and P. O'Byrne, eds. Dekker, New York, pp. 203-238.
2. Karin, M., and F. Saatciolu. 1997. Negative transcriptional regulation by the glucocorticoid receptor is responsible for the anti-inflammalory activity of glueocorticoids. In Inhaled Glucocorticoids in Asthma. R. P. Schleimer, W. Busse, and P. O'Byrne, eds. Dekker, New York, pp. 27-52.
3. Yang-Yen, H., J. Chambard, Y. Sun, T. Smeal, T. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205.
4. Ray, A., K. S. LaForge, and P. B. Sehgal. 1990. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol. Cell. Biol. 10:5736.
5. Kerppola, T., D. Luk, and T. Curran. 1993. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol. Cell. Biol. 13:3782.
6. Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 91:752.
7. Auphan, N., J. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosupression by glucocorticoids: inhibition of NF-κB activity through induction of lκB synthesis. Science 270:286.
8. De Bosscher, K., M. L. Schmitz, W. Vanden Berghe, S. Plaisance, W. Fiers, and G. Haegeman. 1997. Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. USA 94:13504.
9. Paul, W. E. 1991. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77:1859.
10. Brown, M. A., and J. Hural 1997. Functions of IL-4 and control of its expression. Crit. Rev. Imnmnol. 17:1.
11. Rivas, D., L. Mozo, J. Zamorano, A. Gayo, J. C. Torre-Alonso, A. Rodriguez, and C. Gutierrez. 1995. Up-regulated expression of IL-4 receptors and increased levels of IL-4 in rheumatoid arthritis patients. J. Autoimmun. 8:587.
12. Casolaro, V., S. Georas, Z. Song, and S. Ono. 1996. Biology and genetics of atopic disease. Curr. Opin. Immunol. 8:796.
13. Chan, S. C., M. A. Brown, T. M. Willcox, S. H. Li, S. R. Stevens, D. Tara, and J. M. Hanifin. 1996. Abnormal IL-4 gene expression by atopic dermatitis T lymphocytes is reflected in altered nuclear protein interactions with IL-4 transcriptional regulatory element. J. Invest. Dermatol. 106:1131.
14. Rosenwasser, L. J. 1997. Interleukin-4 and the genetics of atopy. N. Engl. J. Med. 337:1766.
15. Wilson, S. B., S. C. Kent, K. T. Patton, T. Orban, R. A. Jackson, M. Exley, S. Porcelli, D. A. Schatz, M. A. Atkinson, S. P. Balk, et al. 1998. Extreme Th1 bias of invariant V24JQ T cells in type 1 diabetes. Nature 391:177.
16. Robinson, D., Q. Hamid, S. Ying, A. Bentley, B. Assoufi, S. Durham, and A. B. Kay. 1993. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression. Am. Rev. Respir. Dis. 148:401.
17. Masuyama, K., M. Jacobson, S. Rak, Q. Meng, R. Sudderick, A. N. Kay, O. Lowhagen, Q. Hamid, and S. Durham. 1994. Topical glucocorticosteroid (fluticasone proprionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 82:192.
18. Bentley, A., Q. Hamid, D. Robinson, E. Schotman, Q. Meng, B. Assoufi, A. B. Kay, and S. Durham. 1996. Prednisolone treatment in asthma: reduction in the number of eosinophils, T cells, mast cells, and modulation of IL-4, IL-5 and IFN-γ cytokine gene expression within the bronchial mucosa. Am. J. Respir. Crit. Care Med. 153:551.
19. Wu, C., C. Fargeas, T. Nakajima, and G. Delespesse. 1991. Glucocorticoids suppress the production of interleukin-4 by human lymphocytes. Eur. J. Immunol. 21:2645.
20. Braun, C. M., S. K. Huang, G. G. Bashian, A. Kagey-Sobotka, L. M. Lichtenstein, and D. M. Essayan. 1997. Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. J. Allergy Clin. Immunol. 100:400.
21. Schroeder, J. T., D. W. MacGlashan, Jr., S. M. MacDonald, A. Kagey-Sobotka, and L. M. Lichtenstein. 1997. Regulation of IgE-dependent IL-4 generation by human basophils treated with glucocorticoids. J. Immunol. 158:5448.
22. Yoshikawa, H., Y. Nakajima, and K. Tasaka. 1999. Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression. J. Immunol. 162:6162.
23. Abe, E., R. De Waal Malefyt, I. Matsuda, K. Arai, and N. Arai. 1992. An 11 base-pair DNA sequence motif apparently unique to human interleukin 4 gene confers responsiveness to T-cell activation signals. Proc. Natl. Acad. Sci. USA 89:2864.
24. Szabo, S., J. Gold, T. Murphy, and K. Murphy. 1993. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-AT. Mol. Cell. Biol. 13:4793.
25. Chuvpilo, S., C. Schomberg, R. Gerwig, A. Heinfling, R. Reeves, F. Grummt, and F. Serfling. 1993. Multiple closely linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res. 21:5694.
26. Todd, M., M. Grusby, J. Lederer, E. Lacy, A. Lichtman, and L. Glimcher. 1993. Transcription of the interleukin 4 gene is regulated by multiple promoter elements. J. Exp. Med. 177:1663.
27. Li-Weber, M., I. Davydov, H. Krafft, and P. Krammer. 1994. The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J. Immunol. 153: 4122.
28. Davydov, I., P. Krammer, and M. Li-Weber. 1995. Nuclear factor-IL-6 activates the human IL,-4 promoter in T cells. J. Immunol. 155:5273.
29. Rooney, J., T. Hoey, and L. Glimcher. 1995. Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 2:473.
30. Takemoto, N., N. Koyano-Nakagawa, N. Arai, K. Arai, and T. Yokota. 1997. Four P-like elements are required for optimal transcription of the mouse IL-4 gene: involvement of a distinct set of nuclear factor of activated T cells and activator protein-1 family proteins. Int. Immunol. 9:1329.
31. Ranganath, S., W. Ouyang, D. Bhattarcgarya, W. Sha, A. Grupe, G. Peltz, and K. M. Murphy. 1998. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161:3822.
32. Kubo, M., J. Ransom, D. Webb, Y. Hashimoto, T. Tada, and T. Nakayama. 1997. T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6. EMBO J. 16:4007.
33. Rao, A., C. Luo, and P. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707.
34. Kiani, A., J. Viola, A. Lichtman, and A. Rao. 1997. Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1. Immunity 7:849.
35. Yoshida, H., H. Nishina, H. Takimoto, L. Marengère, A. Wakeham, D. Bouchard, Y.-Y. Kong, T. Ohteki, A. Shahinian, M. Bacjmann, et al. 1998. The transcription factor NF-ATcl regulates lymphocyte proliferation and Th2 cytokine production. Immunity 8:115.
36. Ranger, A., M. Hodge, E. Gravallese, M. Oukka, L. Davidson, F. Alt, F. de la Brousse, T. Hoey, M. Grusby, and L. Glimcher. 1998. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 8:125.
37. Ranger, A. M., M. Oukka, J. Rengarajan, and L. H. Glimcher. 1998. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9:627.
38. Cron, R. Q., S. J. Bort, Y. Wang, M. W. Brunvand, and D. B. Lewis. 1999. T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells. J. Immunol. 162:860.
39. Casolaro, V., S. Georas, Z. Song, I. Zubkoff, S. Abdulkadir, D. Thanos, and S. Ono. 1995. Inhibition of NF-AT-dependem transcription by NF-κB: implications for differential cytokine gene expression. Proc. Natl. Acad. Sci. USA 92: 11623.
40. Paliogianni, F., N. Hama, G. J. Mavrothalassitis, G. Thyphronitis, and D. T. Boumpas. 1996. Signal requirements for interleukin 4 promoter activation in human T cells. Cell. Immunol. 168:33.
41. Kubo, M., R. Kincaid, and J. Ransom. 1994. Activation of the interleukin-4 gene is controlled by the unique calcineruin-dependent transcriptional factor NF(P). J. Biol. Chem. 269:19441.
42. 2+/ calmodulin-activated, phosphoprotein phosphatase calcineurin is sufficient for positive transcriptional regulation of the mouse IL-4 gene. Int. Immunol. 6:179.
43. Clipstone, N., and G. Crabtree. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695.
44. Frantz, B., E. C. Nordby, G. Bren, N. Steffan, C. V. Paya, R. L. Kincaid, M. J. Tocci, S. J. O'Keefe, and E. A. O'Neill. 1994. Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO J. 13:861.
45. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727.
46. Loh, C., K. T. Shaw, J. Carew, J. P. Viola, C. Luo, B. A. Perrino, and A. Rao. 1996. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J. Biol. Chem. 271:10884.
47. Paliogianni, F., and D. T. Boumpas. 1995. Glucocorticoids regulate calcineurin-dependent trans-activating pathways for interleukin-2 gene transcription in human T lymphocytes. Transplantation 59:1333.
48. Northrop, J., G. Crabtree, and P. Mattila. 1992. Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J. Exp. Med. 175:1235.
49. Vacca, A., M. Felli, A. Farina, S. Martinotti, M. Maroder, I. Screptanti, D. Meco, E. Petrangeli, L. Frati, and A. Gulino. 1992. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-I enchancer elements. J. Exp. Med. 175:637.
50. Otsuka, T., D. Villaret, T. Yokota, Y. Takebe, F. Lee, N. Arai, and K. Arai. 1987. Structural analysis of the mouse chromosomal gene encoding interleukin 4 which expresses B cell, T cell and mast cell stimulating activities. Nucleic Acids Res. 15:333.
51. Durand, D., J. Shaw, M. Bush, R. Replogle, R. Belagaje, and G. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enchancer. Mol. Cell. Biol. 8:1715.
52. Hollenberg, S., C. Weinberger, E. Ong, O. Cerelli, A. Oro, R. Lebo, E. Thompson, M. Rosenfeld, and R. Evans. 1985. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318:635.
53. O'Keefe, S. J., J. Tamura, R. L. Kincaid, M. J. Tocci, and E. A. O'Neill. 1992. FK-506-and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357:692.
54. Hoey, T., Y. Sun, K. Williamson, and X. Xu. 1995. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity 2:461.
55. Helmberg, A., N. Auphan, C. Caelles, and M. Karin. 1995. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 14:452.
56. Schreiber, E., P. Matthias, M. Müller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with mini-extracts from a small number of cells. Nucleic Acids Res. 17:6419.
57. Jain, J., E. Burgeon, T. Badalian, P. Hogan, and A. Rao. 1995. A similar DNA-binding motif in NFAT family proteins and the rel homology region. J. Biol. Chem. 270:4138.
58. Freedman, L., and B. Luisi. 1993. On the mechanism of DNA binding by nuclear hormone receptors: a structural and functional perspective. J. Cell. Biochem. 51:140.
59. Warren, B. S., P. Kusk, R. G. Wolford, and G. L. Hager. 1996. Purification and stabilization of transcriptionally active glucocorticoid receptor. J. Biol. Chem. 271:11434.
60. Tara, D., D. Weiss, and M. Brown. 1993. An activation-responsive element in the murine IL-4 gene is the site of an inducible DNA-protein interaction. J. Immunol. 151:3617.
61. Ho, I. C., M. R. Hodge, J. W. Rooney, and L. H. Glimcher. 1996. The protooncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85:973.
62. Lyakh, L., P. Ghosh, and N. Rice. 1997. Expression of NFAT-family proteins in normal human T cells. Mol. Cell. Biol. 17:2475.
63. Weiss, D., J. Hural, D. Tara, L. Timmerman, G. Henkel, and M. Brown. 1996. Nuclear factor of activated T cells is associated with a mast cell interleukin-4 transcription complex. Mol. Cell. Biol. 16:228.
64. Paliogianni, F., M. Valentine, and D. Boumpas. 1993. Glucocorticoids inhibit calcium-but not protein kinase C-dependent pathways for T cell activation. Arthritis Rheum. 36(Suppl.):S113.
65. Paliogianni, F., S. S. Ahuja, J. P. Balow, J. E. Balow, and D. T. Boumpas. 1993. Novel mechanism for inhibition of human T cells by glucocorticoids: glucocorticoids inhibit signal transduction through IL-2 receptor. J. Immunol. 151:4081.
66. Chuvpilo, S., M. Zimmer, A. Kerstan, J. Glockner, A. Avots, C. Escher, C. Fischer, I. Inashkina, E. Jankevics, F. Berberich-Siebelt, E. Schmitt, and E. Serfling. 1999. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity 10:261.
67. Sherman, M. A., D. R. Powell, D. L. Weiss, and M. A. Brown. 1999. NF-ATc isoforms are differentially expressed and regulated in murine T and mast cells. J. Immunol. 162:2820.
68. Timmerman, L., J. Healy, S. Ho, L. Chen, C. Goodnow, and G. Crabtree. 1997. Redundant expression but selective utilization of NFAT family members. J. Immunol. 159:2735.
69. Loh, C., J. A. Carew, J. Kim, P. G. Hogan, and A. Rao. 1996. T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1. Mol. Cell. Biol. 16:3945.
70. Ranger, A. M., M. J. Grusby, M. R. Hodge, E. M. Gravallese, F. C. de la Brousse, T. Hoey, C. Mickanin, H. S. Baldwin, and L. H. Glimcher. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392:186.
71. Leung, D. Y., R. J. Martin, S. J. Szefler, E. R. Sher, S. Ying, A. B. Kay, and Q. Hamid. 1995. Dysregulation of interleukin 4, interleukin 5, and interferon γ gene expression in steroid-resistant asthma. J. Exp. Med. 181:33.
72. Reichardt, H. M., K. H. Kaestner, J. Tuckermann, O. Kretz, O. Wessely, R. Bock, P. Gass, W. Schmid, P. Herrlich, P. Angel, and G. Schutz. 1998. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93:531.
73. Beals, C. R., C. M. Sheridan, C. W. Turck, P. Gardner, and G. R. Crabtree. 1997. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275:1930.